机译:左非小细胞肺癌中4L转移的预测因子和生存影响
Zhejiang Univ Sch Med Affiliated Hosp 1 Dept Thorac Surg Hangzhou 310003 Zhejiang Peoples R;
Zhejiang Univ Sch Med Affiliated Hosp 1 Dept Thorac Surg Hangzhou 310003 Zhejiang Peoples R;
Zhejiang Univ Sch Med Affiliated Hosp 1 Dept Thorac Surg Hangzhou 310003 Zhejiang Peoples R;
Zhejiang Univ Sch Med Affiliated Hosp 1 Dept Thorac Surg Hangzhou 310003 Zhejiang Peoples R;
Zhejiang Univ Sch Med Affiliated Hosp 1 Dept Thorac Surg Hangzhou 310003 Zhejiang Peoples R;
Zhejiang Univ Sch Med Affiliated Hosp 1 Dept Thorac Surg Hangzhou 310003 Zhejiang Peoples R;
Zhejiang Univ Sch Med Affiliated Hosp 1 Dept Thorac Surg Hangzhou 310003 Zhejiang Peoples R;
Non-small cell lung cancer; Station 4L metastasis; Lymph-node dissection; Prognosis;
机译:左非小细胞肺癌中4L转移的预测因子和生存影响
机译:lncRNA CCHE1增加非小肺癌细胞的增殖,转移和侵袭,并预测非小肺癌患者的不良生存
机译:4L淋巴结解剖早期,左侧,非小细胞肺癌后更好的存活:我们是否争论了错误的二元性?
机译:基因表达谱预测晚期非小细胞肺癌患者的生存
机译:临床相关的HSP90抑制剂Auy922,A549非小细胞肺癌细胞转移和耐药性快速演变和耐药性的快速演变
机译:左上分区非小细胞肺癌的淋巴结转移及预后:叶间淋巴结转移的影响
机译:EP1.18-29外科治疗后4r或10r单驻于单驻于淋巴结转移的非小细胞肺癌患者的存活